Kevin Boyle Sr - Chief Executive Officer, Ziopharm Oncology Inc

As of November 17, 2021


Kevin Boyle Sr Net Worth

  • Owns at least 885,000 units of Ziopharm Oncology Inc stock

Kevin Boyle Sr Trading

  • Largest purchase of shares was 10,000 units , worth over $14K on November 17, 2021
  • In total has made about 2 transactions over 3 months
  • Usually trades in August and November, with the busiest year in 2021
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Kevin Boyle Sr Mailing Address

  • Mailing address is C/o Ziopharm Oncology, Inc. One First Avenue, Parris Bldg 34 Boston MA 02129 MA

Ziopharm Oncology Inc Insider Trading

  • The most recent transaction was 20,132 units sold on December 27, 2021 by Eleanor de Groot worth over $25.57K
  • In the last 14 years, insiders at Ziopharm Oncology Inc sold an estimated value of $13.56M and bought an estimated value of $76.75M
  • The most active traders are Randal Kirk, Director,  Intrexon Corp,  and Anthony James Cannon, Director
  • Insider trading is most common in January, with the busiest year in 2017

ZIOPHARM ONCOLOGY INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1